Help & Guidance — Purple Haze MK
Why Is Weed Illegal?
Cannabis is a Class B controlled substance in the UK under the Misuse of Drugs Act 1971. Its illegal status reflects a complex mix of health concerns, international treaty obligations, political decisions and historical context — not simply a straightforward scientific consensus. This article explains how cannabis came to be illegal, the arguments that have maintained that status and the evolving global debate around reform.
Cannabis is illegal in the UK primarily because of the Misuse of Drugs Act 1971, which classified it as a Class B substance — placing it alongside amphetamines and synthetic cannabinoids. This classification reflects concerns about mental health risks (particularly psychosis and cannabis use disorder), the gateway drug theory, social harm reduction policy and the UK's obligations under three United Nations drug control treaties signed between 1961 and 1988. The scientific debate about whether the current classification reflects the actual evidence-based harm profile of cannabis compared to legal substances like alcohol and tobacco has been ongoing for decades — but the legal status has remained Class B, with the exception of a brief reclassification to Class C between 2004 and 2009. The question of why cannabis is illegal has both historical and political dimensions that go well beyond simple public health evidence.
How Cannabis Became Illegal: A Timeline
First UK restriction — Dangerous Drugs Act
Cannabis (listed as Indian hemp) was added to the Dangerous Drugs Act 1920 via amendment in 1928, largely following international pressure from the League of Nations' 1925 Geneva Convention on opium and other drugs, which added cannabis to its schedule. Cannabis use was rare in the UK at this time and the restriction attracted little public attention.
UN Single Convention on Narcotic Drugs
The United Nations Single Convention on Narcotic Drugs 1961 — the cornerstone of international drug control — placed cannabis in Schedule IV alongside heroin (the most restricted category). As a UN signatory, the UK was bound to maintain cannabis prohibition under international treaty law. This treaty remains the primary structural reason why cannabis cannot simply be legalised by an Act of Parliament without also renegotiating treaty obligations.
Misuse of Drugs Act — Class B classification
The Misuse of Drugs Act 1971 replaced earlier legislation and created the A, B and C classification system still used today. Cannabis was placed in Class B. The Wootton Report of 1968 had recommended a more lenient approach based on evidence, but the government rejected its conclusions in the politically charged context of growing youth drug use, instead establishing the classification that persists — with one interruption — to the present day.
Reclassified to Class C
Following a review by the Advisory Council on the Misuse of Drugs (ACMD), the government reclassified cannabis from Class B to Class C in January 2004, reducing the maximum possession penalty. This reflected evidence that cannabis caused less harm than Class B drugs. However possession remained illegal.
Returned to Class B
Despite the ACMD recommending it remain Class C, then-Home Secretary Jacqui Smith moved cannabis back to Class B in January 2009, citing concerns about high-potency "skunk" cannabis and mental health. Professor David Nutt, then chair of the ACMD, was subsequently dismissed after publicly criticising the decision as politically motivated rather than evidence-based — a controversy that highlighted the tension between scientific advice and political decisions in drug policy.
Medical cannabis legalised
Following high-profile cases involving children with severe epilepsy whose cannabis-based medicines were confiscated, the government legalised cannabis-based products for medicinal use in November 2018. Specialist doctors can now prescribe cannabis-derived medicines. This acknowledged that cannabis has legitimate medical applications while recreational use remained illegal.
Class B — no change
Cannabis remains Class B in the UK. Multiple jurisdictions globally have moved toward decriminalisation or full legalisation — Germany in 2024, Czech Republic in 2026, numerous US states and Canada. UK policy has not followed this trend despite continued public debate about reform.
The Arguments For and Against Continued Prohibition
Arguments for maintaining prohibition
- Mental health risks: regular high-potency cannabis use is associated with increased risk of psychosis and cannabis use disorder, particularly for young people and those with genetic vulnerability.
- Gateway concern: some research suggests cannabis use increases the likelihood of using other drugs, though the causal mechanism is disputed.
- Youth protection: legal frameworks limit youth access, and evidence from legalised jurisdictions on long-term youth use effects is still accumulating.
- International treaty obligations: renegotiating the 1961 UN Single Convention would be required for full legalisation.
- Potency increase: average THC content has risen dramatically since the 1970s, meaning the substance is materially different from when policy was originally set.
Arguments for reform or legalisation
- Harm comparison: cannabis is generally considered less harmful than alcohol and tobacco, both of which are legal and taxed. The Royal College of Physicians has highlighted this inconsistency.
- Criminalisation harm: arresting and prosecuting cannabis users creates collateral harm — criminal records, employment loss — that may exceed the harm of cannabis itself.
- Black market danger: prohibition creates an unregulated supply chain with no quality control, where users cannot know what they are actually consuming.
- Revenue and policing: legalisation would generate substantial tax revenue and free police resources currently spent on cannabis enforcement.
- Evidence from reform: Canada, Colorado, Netherlands and Czech Republic provide real-world data on regulated markets. Early evidence does not show the catastrophic outcomes prohibition advocates predicted.
- Racial disparity: research consistently shows cannabis laws are enforced disproportionately against Black and minority ethnic communities in the UK.
Cannabis has been restricted in the UK for nearly a century — first under the Dangerous Drugs Act 1928, then Class B under the Misuse of Drugs Act 1971
The 1961 UN Single Convention on Narcotic Drugs places cannabis in its most restricted schedule — the UK as a signatory cannot simply legalise without renegotiating treaty obligations
Specialist doctors can prescribe cannabis-based medicines in the UK since November 2018 — acknowledging legitimate medical applications while recreational use remains Class B
The Current UK Legal Position in 2026
Cannabis is a Class B controlled substance under the Misuse of Drugs Act 1971. The penalties are:
- Possession for personal use: up to five years imprisonment plus an unlimited fine.
- Supply and production: up to fourteen years imprisonment plus an unlimited fine.
- In practice, police and prosecutors exercise significant discretion, and first-time personal possession offences may result in a cannabis warning, a Penalty Notice for Disorder or a conditional caution rather than prosecution — but there is no legal guarantee of this approach.
- A cannabis warning remains on the police national computer and can affect DBS checks and some employment and visa applications.
The question of why cannabis is illegal is genuinely complex. The initial prohibition in 1928 predated most scientific knowledge about the substance. The 1971 classification was made in a politically charged atmosphere and has been criticised by multiple expert advisory bodies as not reflecting the evidence-based harm profile of cannabis relative to legal drugs. At the same time, growing evidence about mental health risks — particularly from high-potency cannabis and young users — provides a genuine public health rationale that proponents of prohibition cite. The current legal status reflects political decisions that have not tracked scientific evidence as closely as the architects of the ACMD system intended, as illustrated by the 2009 sacking of Professor David Nutt. Whether cannabis should remain illegal is one of the more actively debated drug policy questions in the UK, with a growing number of politicians, health experts and former law enforcement officers supporting reform.
Part of Our Guide
Help & Guidance Centre
This article is part of the Purple Haze MK Help and Guidance Centre. For more cannabis and CBD guidance, visit the Purple Haze MK Help and Guidance Centre.
Frequently Asked Questions
Why is alcohol legal but cannabis is not?
This is the question that most directly challenges the consistency of UK drug policy. Alcohol causes more deaths, more hospital admissions and more societal harm than cannabis by most public health measures — yet is legal, taxed and widely advertised. The honest answer is that alcohol's legal status reflects its deep cultural embeddedness in British society over centuries and the political impracticality of prohibition, not a comparative harm assessment. Cannabis was prohibited when it was not yet culturally embedded in the mainstream, before the regulatory infrastructure of legalisation was conceivable and under significant international pressure. The inconsistency is acknowledged by many public health researchers and drug policy experts, including several former government advisors.
Will cannabis ever be legalised in the UK?
As of 2026, no UK government has committed to legalisation or decriminalisation of recreational cannabis. The Liberal Democrats have a policy of legalisation and regulation; the Greens support decriminalisation; the Labour and Conservative parties have not moved toward reform. Public support for some form of reform has grown significantly — polls consistently show majority support for at least decriminalisation among UK adults. Given the pace of reform in comparable countries including Germany and Czech Republic, many drug policy experts consider it likely that UK policy will shift in the medium term, though the timeline is uncertain.
Is cannabis legal anywhere for personal use in Europe?
Yes. Germany legalised personal cannabis possession and home cultivation for adults from 1 April 2024 under the Cannabis Act, though retail sales remain limited to pilot programmes. The Czech Republic enacted full possession legalisation from 1 January 2026. The Netherlands has long-operated a tolerance framework for cannabis coffee shops. Portugal decriminalised possession of all drugs in 2001. Switzerland operates a pilot programme. European drug policy is moving broadly in the direction of reform, with the UK being one of the more conservative major European nations on this question.
Related Articles
For more cannabis and CBD guidance, visit the Purple Haze MK Help and Guidance Centre.
Legal CBD Products in Milton Keynes
Purple Haze MK — CBD and Vaping Specialists
For legal CBD products and vaping accessories in Milton Keynes, visit us at Stall 109, Milton Keynes Market. Tue, Thu to Sat 9am to 5:30pm. Sun 10am to 5pm.